Harbor MedTech, Inc.
Harbor MedTech, Inc. is a fully integrated, commercial-stage regenerative medicine company with a patented technology.
Our BriDGE® platform creates a stabilized collagen matrix that prevents our products from degrading; thus allowing them to heal in as few as one application.
Our first BriDGE® technology product, Architect®, is FDA cleared and CE marked for healing chronic skin wounds.
Architect® upregulates the patient’s own immune response to accelerate healing, reduce biofilm formation, and can treat patients in as few as one application.
Leveraging the BriDGE® platform, Harbor MedTech has a robust pipeline, including products that meet significant unmet needs in breast reconstruction, hernia repair, Achilles tendon and rotator cuff repair as well as many other surgical applications.